This study aimed to evaluate the effects of GLP-1 RAs on ocular surface health in patients with T2DM
At its heart will be a move away from relying on overly simplistic BMI, which does not account for a persons gender, age or body composition of fat vs
3) Avoid making sudden changes Resist the urge to rapidly change dose, eating patterns, or routines without guidance
Can genetic variants in GLP1R or GIPR explain why someone may not lose weight on GLP-1
The Lancet (2025): Once-weekly semaglutide 72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial.EMC (2026): Wegovy 7.2 mg Solution for injection in pre-filled pen Patient Information Leaflet
Storage Quick Reference Community sources commonly describe storing unopened vials frozen, with reconstitution limited to a 3-4 week supply